Where the Money Goes

You are here

Home » Cure4Cam Childhood Cancer Foundation

Cure4Cam Childhood Cancer Foundation

The Cure4Cam Childhood Cancer Foundation supports the development of new, more effective and safer therapies to treat childhood cancer. Today’s standard treatments can be highly toxic, creating intolerable side effects and causing lasting health issues. Cure4Cam was founded in honor of Cameron Evans, a top runner for his middle school cross country team with a passion for technology, who, only days after competing in a middle school championship cross country race, was diagnosed with leukemia. After a tough fight, Cameron passed away at age 14. The Cure4Cam Foundation raises money to fund new and innovative cancer research to develop therapies that target individual cancer cells.

Visit Cure4Cam Childhood Cancer Foundation for more information

Co-Funded Projects

Project Title Institutions Co-Funder(s)
Targeting Protein Translation to Antagonize MYC-driven Neuroblastoma Children’s Hospital of Philadelphia Cure4Cam Childhood Cancer Foundation
Novel Approaches for Epigenetic Therapy for Relapsed Acute Lymphoblastic Leukemia The Johns Hopkins University School of Medicine Cure4Cam Childhood Cancer Foundation
Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma Baylor College of Medicine Chance for Life, Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Turn It Gold
CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors St. Jude Children’s Research Hospital Cure4Cam Childhood Cancer Foundation
Targeting Microenvironmental Support of Acute Lymphoblastic Leukemia University of Rochester Cure4Cam Childhood Cancer Foundation
Improving Immune-Mediated Oncolytic Viral Therapy: Engineering Tumor Vaccine Elements into the Virus Research Institute at Nationwide Children's Hospital Cure4Cam Childhood Cancer Foundation, Flashes of Hope
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma Virginia Commonwealth University Cure4Cam Childhood Cancer Foundation, I Care I Cure
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy University of North Carolina Cure4Cam Childhood Cancer Foundation, I Care I Cure
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma Children’s Hospital Los Angeles Cure4Cam Childhood Cancer Foundation, Flashes of Hope
Optimizing Bispecific Antibody Therapy for Acute Leukemias Fred Hutchinson Cancer Research Center Cure4Cam Childhood Cancer Foundation

Pages

Featured Hero

Connor Whaley

The best words to describe Connor are funny, goofy and loving. He is naturally strong and resilient, especially as he’s fighting his B cell acute lymphoblastic leukemia. Connor's treatment has been tough, but today he is in the maintenance stage.
Read more »